ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Machine Learning-Guided Engineering of Protein Phase Separation Properties in Immune Regulation.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Engineering Design of Artificial Phase-Separating Proteins.Biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Phase separation (PS) underpins compartmentalization in living cells, facilitating the formation of membraneless organelles and the regulation of cellular processes. Despite the increasingly pivotal role of engineering protein PS properties in the study and regulation of cellular physiological processes, manipulating PS ability through single amino acid alterations remains a challenge. Here, we develop phase separation scalpel (PScalpel), a machine learning-based tool identifying and recommends protein engineering strategies for directed changes in PS ability. Based on our biological experimental data, we apply transfer learning to achieve the feedback-driven optimization of specific protein prediction accuracy--markedly enhancing the predictive performance for TDP43, a neurodegenerative disease-associated protein. Furthermore, by engineering the crucial nucleic acid sensor cGAS as a model application, we successfully modulate its PS ability in the anticipated direction by altering a single amino acid, which subsequently optimizes its immune function and impacts the activity of engineered macrophages. Transcriptomic analysis of these cGAS-engineered macrophages further demonstrated that the immune function of macrophages can be altered by the manipulation of cGAS PS ability. In summary, PScalpel is an effective tool for guiding PS ability engineering, enabling targeted molecular and cellular modifications and providing nuanced methods for precise biomolecular engineering in future research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.